Diferencia entre revisiones de «Irritable bowel syndrome»
Sin resumen de edición |
|||
| Línea 2: | Línea 2: | ||
#psychosocial factors | #psychosocial factors | ||
#altered gut motility | #altered gut motility | ||
#hypersensitive intestinal pain | #hypersensitive intestinal pain perception | ||
==Evaluation== | ==Evaluation== | ||
===Criteria=== | ===Criteria=== | ||
#Three months of pain: | #Three months of [[abdominal pain]]: | ||
##relieved by defecation | ##relieved by defecation | ||
##associated with change of stool freq | ##associated with change of stool freq | ||
| Línea 22: | Línea 22: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*[[Post-infectious irritable bowel syndrome]] | *[[Post-infectious irritable bowel syndrome]] | ||
*See [[abdominal pain]] | |||
==Management== | ==Management== | ||
*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref> | *Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref> | ||
*Typical bowel regimen treatments for IBS-C | *Typical bowel regimen treatments for IBS-C | ||
**May consider low-dose TCA if appropriate follow up with PCP will occur | **May consider low-dose [[TCA]] if appropriate follow up with PCP will occur | ||
==See Also== | ==See Also== | ||
Revisión del 21:47 29 sep 2019
Background
- psychosocial factors
- altered gut motility
- hypersensitive intestinal pain perception
Evaluation
Criteria
- Three months of abdominal pain:
- relieved by defecation
- associated with change of stool freq
- related to a change in stool consistency
- AND, 2 or more of the following symptoms 25% of the time
- >3 bm per day or < 3 bm per week
- altered stool form
- altered stool passage
- passage of mucous
- bloating
Workup
- Diagnosis of exclusion
Differential Diagnosis
Management
- Consider prescribing ondansetron up to 24 mg/d for IBS-D[1]
- Typical bowel regimen treatments for IBS-C
- May consider low-dose TCA if appropriate follow up with PCP will occur
See Also
External Links
Patient Information
Irritable Bowel Syndrome (National Digestive Diseases Information Clearinghouse)
References
- ↑ Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.